Developer docs
API playgroundTry for free, no card

Search company profiles

Circe

Full company profile

uuid0000cpa

Namestring
Circe
Legal namestring
Circe
Company typeenum
Private
Founded yearint
2021
Short descriptiontext

Circe is a Boston-based climate biotech, spun out of Harvard's Wyss Institute, that uses proprietary gas fermentation to convert CO2 into carbon-negative oils, butters, sugars, fuels, and plastics for enterprise customers in food, chemical, and fuel manufacturing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gas fermentation technology, carbon-negative ingredients, CO2-to-molecule bioconversion, sustainable industrial biotechnology, engineered microbial fermentation
Industry1 code
PRIMARYIMAEADAC
C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid)
NAICS code3 codes
  • Basic Chemical Manufacturing3251
  • Other Basic Organic Chemical Manufacturing32519
  • Chemical Manufacturing325
Product category
Industrial Biotechnology / Carbon-Negative Ingredient Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Carbon-negative Molecule Sales
TypeHardware Sales
Description

Circe produces and sells carbon-negative molecules (fats, oils, and other chemicals) manufactured via gas fermentation. The company targets industrial customers in food, chemical, and fuel manufacturing sectors who need sustainable ingredient alternatives.

circebioscience.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Circe manufactures and sells carbon-negative molecules — including oils, butters, sugars, fuels, and plastics — produced via proprietary gas fermentation that converts CO2 and hydrogen into high-value chemicals using engineered microbes. The company sells these drop-in ingredient equivalents directly to industrial manufacturers in the food, chemical, and fuel sectors, removing 3 kilograms of CO2 per 1 kilogram of product produced.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 3 kg CO2 removed per 1 kg product produced
Product and service5 records
1Oils
CategoryCore product — Sustainable oils
Description

Carbon-negative oils produced via gas fermentation using CO2, water, and electricity as feedstocks, serving as sustainable, drop-in alternatives to traditionally manufactured oils for food, chemical, and industrial manufacturers.

2Butters
CategoryCore product — Sustainable butters and fats
Description

Sustainable butter alternatives produced through gas fermentation, including fats like milkfat and palm oil equivalents, created by engineered microbes consuming greenhouse gases; serves food manufacturers seeking drop-in fat ingredients.

3Sugars
CategoryCore product — Sustainable sugars
Description

Carbon-negative sugars produced via gas fermentation, providing sustainable alternatives for food and chemical manufacturing applications where traditional sugar feedstocks are required.

4Fuels
CategoryCore product — Sustainable biofuels
Description

Biofuels produced through gas fermentation technology that absorbs CO2 during production, offering sustainable fuel alternatives that reduce industrial carbon emissions for fuel producers.

5Plastics
CategoryCore product — Biodegradable plastics
Description

Biodegradable plastics produced via carbon-negative manufacturing processes that utilize CO2 as a resource, providing sustainable alternatives to carbon-intensive chemical manufacturing.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-05-01
Description

Exclusive licensing agreement with Harvard's Wyss Institute to commercialize gas fermentation technology. The technology uses microbes to eat greenhouse gases and produce valuable products. This is the foundational technology upon which Circe's business is built.

Market position
Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Circe

Industrial Biotechnology / Carbon-Negative Ingredient Manufacturingcircebioscience.com

Circe is a Boston-based climate biotech, spun out of Harvard's Wyss Institute, that uses proprietary gas fermentation to convert CO2 into carbon-negative oils, butters, sugars, fuels, and plastics for enterprise customers in food, chemical, and fuel manufacturing.

Circe firmographics

Firmographics
Name
Circe
Legal name
Circe
Website
https://circebioscience.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
Circe is a Boston-based climate biotech, spun out of Harvard's Wyss Institute, that uses proprietary gas fermentation to convert CO2 into carbon-negative oils, butters, sugars, fuels, and plastics for enterprise customers in food, chemical, and fuel manufacturing.
Ownership category
akta.pro rank

Circe industry classification

Industry
Product category
Industrial Biotechnology / Carbon-Negative Ingredient Manufacturing
NAICS
Basic Chemical Manufacturing (3251), Other Basic Organic Chemical Manufacturing (32519), Chemical Manufacturing (325)
akta.pro industry
PRIMARYIMAEADAC
C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid)

Keywords

  • Gas fermentation technology
  • Carbon-negative ingredients
  • CO2-to-molecule bioconversion
  • Sustainable industrial biotechnology
  • Engineered microbial fermentation

Where Circe is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Circe business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Infrastructure, Supply Chain

Revenue model

  1. Carbon-negative Molecule Sales: Circe produces and sells carbon-negative molecules (fats, oils, and other chemicals) manufactured via gas fermentation. The company targets industrial customers in food, chemical, and fuel manufacturing sectors who need sustainable ingredient alternatives.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Circe product offering

Product offering

Core offering

Circe manufactures and sells carbon-negative molecules — including oils, butters, sugars, fuels, and plastics — produced via proprietary gas fermentation that converts CO2 and hydrogen into high-value chemicals using engineered microbes. The company sells these drop-in ingredient equivalents directly to industrial manufacturers in the food, chemical, and fuel sectors, removing 3 kilograms of CO2 per 1 kilogram of product produced.

Differentiator

Problem solved

Functional benefit

Products and services

  • Oils Carbon-negative oils produced via gas fermentation using CO2, water, and electricity as feedstocks, serving as sustainable, drop-in alternatives to traditionally manufactured oils for food, chemical, and industrial manufacturers.
  • Butters Sustainable butter alternatives produced through gas fermentation, including fats like milkfat and palm oil equivalents, created by engineered microbes consuming greenhouse gases; serves food manufacturers seeking drop-in fat ingredients.
  • Sugars Carbon-negative sugars produced via gas fermentation, providing sustainable alternatives for food and chemical manufacturing applications where traditional sugar feedstocks are required.
  • Fuels Biofuels produced through gas fermentation technology that absorbs CO2 during production, offering sustainable fuel alternatives that reduce industrial carbon emissions for fuel producers.
  • Plastics Biodegradable plastics produced via carbon-negative manufacturing processes that utilize CO2 as a resource, providing sustainable alternatives to carbon-intensive chemical manufacturing.

Quantifiable outcome

  • 3 kg CO2 removed per 1 kg product produced

Companies that use Circe

Customer profile

Segments3 records

Ideal customer profiles3 records

Circe technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Circe partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Harvard University Wyss InstitutecoreOEM/ Whitelabel/ Licensing Partner · 1 May 2024Exclusive licensing agreement with Harvard's Wyss Institute to commercialize gas fermentation technology. The technology uses microbes to eat greenhouse gases and produce valuable products. This is the foundational technology upon which Circe's business is built.

Scale indicators3 records

Circe competitors and assessment

Company assessment

Market position

Customer concentration

Circe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Circe leadership team

Management profile

Number of profiles

Profiles1 record

Circe funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Circe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Circe

What does Circe do?

Circe manufactures and sells carbon-negative molecules — including oils, butters, sugars, fuels, and plastics — produced via proprietary gas fermentation that converts CO2 and hydrogen into high-value chemicals using engineered microbes. The company sells these drop-in ingredient equivalents directly to industrial manufacturers in the food, chemical, and fuel sectors, removing 3 kilograms of CO2 per 1 kilogram of product produced.

Is Circe a public or private company?

Circe is a private company. It is classified as venture growth investor backed and is currently operating.

When was Circe founded?

Circe was founded in 2021. It employs 51 to 100 people.

Where is Circe based?

Circe is headquartered in Boston, United States, in the North America region.

How does Circe make money?

One revenue line is on record: carbon-negative Molecule Sales.

Does Circe have an API?

No public API is recorded for Circe.

What industry is Circe in?

Circe's product category is Industrial Biotechnology / Carbon-Negative Ingredient Manufacturing. Its primary akta.pro industry code is IMAEADAC, C1 & Synthesis Gas Derivatives (Methanol, Formaldehyde, Acetic Acid). Its NAICS code is 3251.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Styleblueprint14 Best Women’s Boutiques in LouisvilleThe article highlights the top women's boutiques in Louisville, detailing various stores that offer clothing, accessories, and gifts, such as Clay & Cotton, Circe, Hazel + Hunt, and others. It provides descriptions of each boutique, their locations, and offerings. The article encourages supporting local businesses and shopping in Louisville.Climatehack🧊 ClimateHack Vol 113: $55M to cool down AI centresClimateHack Vol 113 reports on multiple climate technology funding rounds, highlighting Submer's $55.5 million raise for AI data center cooling and Circe Bioscience's $5 million seed round for carbon-negative molecules. The newsletter also covers investments in agri-food startups like Entosystem and AgroSpheres, as well as strategic moves in mobility and materials sectors. Additionally, it notes regulatory delays in the EU and consumer protection issues regarding UK retailers' recycling schemes.BiofuelsdigestCirce raises $5 million to advance Wyss Institute process : The Daily DigestCirce has secured a $5 million seed funding round to advance its gas fermentation technology, which converts CO2, water, and electricity into sustainable products like sugars, fats, and biofuels. The company licensed the underlying process from Harvard University’s Wyss Institute and has installed a pilot plant in Waltham, Massachusetts to scale production beyond proof-of-concept.GlobeNewswireCirce Announces $5M Seed Round and Pilot PlantCirce, a carbon-negative manufacturing company based in Boston, announced a $5 million seed funding round and the installation of a pilot plant in Waltham, Massachusetts. The new facility, accelerated by an ARPA-E contract, will allow Circe to scale production of carbon-negative fats and oils using advanced gas fermentation technology that consumes CO2. This development marks a transition from lab-based proof of concept to commercial-scale manufacturing for sustainable chemical alternatives.DecarbonfuseCirce Announces $5M Seed Round and Pilot PlantCirce, a carbon-negative manufacturing company, announced a $5 million Seed Round to support its pilot plant in Waltham, MA. The funding, backed by several investors, will enable Circe to scale the production of sustainable fats and oils, which are crucial for reducing global emissions. Circe aims to achieve cost parity with traditional production methods while focusing on innovative products made from CO2.VC News DailyCirce Bioscience Lands $8M FundingCirce Bioscience, a startup spun out of Harvard University's Wyss Institute, has raised more than $8 million in funding. The company secured this capital to commercialize a novel bioproduction technology licensed exclusively from the institute, which aims to significantly reduce carbon emissions across various industries.iHeartGreater Boston Startup Is Using Fermentation To Decarbonize ManufacturingCirce Bioscience, a startup founded in 2021 out of Harvard University research, is developing a fermentation process that transforms carbon dioxide emissions into organic molecules including fats, oils, and compounds like cocoa butter. The company signed a worldwide exclusive licensing agreement through Harvard's Office of Technology Development to commercialize their bioproduction technology and is a few months away from launching their prototype in Waltham, Massachusetts. The startup aims to combat climate change by replacing traditional sources like palm oil and cacao with sustainable, CO2-derived alternatives.confectionerynews.comHow scientists created a chocolate bar out of thin airCirce Bioscience, a startup from Harvard's Wyss Institute, created a gas fermentation-based chocolate using microbes to produce cocoa butter. The technology converts greenhouse gases into fats and oils, potentially addressing the 2023-2024 cocoa shortage. Circe has secured over $8 million in funding.confectionerynews.comHow scientists created a chocolate bar out of thin airCirce Bioscience, a biotech startup, has created cocoa butter from greenhouse gas emissions using microbes, producing the world's first gas fermentation-based chocolate. The technology, developed at Harvard's Wyss Institute, converts CO2 and H2 into fats and oils, and Circe has secured over $8 million in funding.Harvard GazetteCirce Bioscience licenses technology to decarbonize industry with…Circe Bioscience has signed a worldwide, exclusive licensing agreement with Harvard University's Office of Technology Development to commercialize its gas fermentation technology for decarbonizing industrial processes. The startup, which has raised over $8 million from investors including Regen Ventures and Undeterred Capital, utilizes engineered microbes to convert greenhouse gases into valuable products such as fats and biofuels.